1055 related articles for article (PubMed ID: 16634839)
21. Risk factors for development of diabetes mellitus in women with a history of gestational diabetes mellitus.
Bian X; Gao P; Xiong X; Xu H; Qian M; Liu S
Chin Med J (Engl); 2000 Aug; 113(8):759-62. PubMed ID: 11776065
[TBL] [Abstract][Full Text] [Related]
22. Recurrence of gestational diabetes mellitus: identification of risk factors.
Spong CY; Guillermo L; Kuboshige J; Cabalum T
Am J Perinatol; 1998 Jan; 15(1):29-33. PubMed ID: 9475684
[TBL] [Abstract][Full Text] [Related]
23. Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.
Mertens I; Ballaux D; Funahashi T; Matsuzawa Y; Van der Planken M; Verrijken A; Ruige JB; Van Gaal LF
Thromb Haemost; 2005 Dec; 94(6):1190-5. PubMed ID: 16411393
[TBL] [Abstract][Full Text] [Related]
24. Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy.
McLachlan KA; O'Neal D; Jenkins A; Alford FP
Diabetes Metab Res Rev; 2006; 22(2):131-8. PubMed ID: 16170833
[TBL] [Abstract][Full Text] [Related]
25. Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients.
Kitagawa N; Yano Y; Gabazza EC; Bruno NE; Araki R; Matsumoto K; Katsuki A; Hori Y; Nakatani K; Taguchi O; Sumida Y; Suzuki K; Adachi Y
Diabetes Res Clin Pract; 2006 Aug; 73(2):150-7. PubMed ID: 16458385
[TBL] [Abstract][Full Text] [Related]
26. Differences in insulin sensitivity in pregnant women with overweight and gestational diabetes mellitus.
Endo S; Maeda K; Suto M; Kaji T; Morine M; Kinoshita T; Yasui T; Irahara M
Gynecol Endocrinol; 2006 Jun; 22(6):343-9. PubMed ID: 16785160
[TBL] [Abstract][Full Text] [Related]
27. Normal glucose tolerance and gestational diabetes mellitus: what is in between?
Di Cianni G; Seghieri G; Lencioni C; Cuccuru I; Anichini R; De Bellis A; Ghio A; Tesi F; Volpe L; Del Prato S
Diabetes Care; 2007 Jul; 30(7):1783-8. PubMed ID: 17416793
[TBL] [Abstract][Full Text] [Related]
28. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
Pannacciulli N; De Mitrio V; Marino R; Giorgino R; De Pergola G
Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
[TBL] [Abstract][Full Text] [Related]
29. Blood pressure and lipid changes in gestational diabetes mellitus.
Szymanska M; Bomba-Opon DA; Wielgos M
Neuro Endocrinol Lett; 2008 Jun; 29(3):328-33. PubMed ID: 18580853
[TBL] [Abstract][Full Text] [Related]
30. Does parity increase insulin resistance during pregnancy?
Seghieri G; De Bellis A; Anichini R; Alviggi L; Franconi F; Breschi MC
Diabet Med; 2005 Nov; 22(11):1574-80. PubMed ID: 16241924
[TBL] [Abstract][Full Text] [Related]
31. Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?
Mertens I; Van der Planken M; Corthouts B; Van Gaal LF
Metabolism; 2006 May; 55(5):650-5. PubMed ID: 16631442
[TBL] [Abstract][Full Text] [Related]
32. Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system.
Sills ES; Drews CD; Perloe M; Tucker MJ; Kaplan CR; Palermo GD
Gynecol Endocrinol; 2003 Jun; 17(3):231-7. PubMed ID: 12857431
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of impaired glucose tolerance 6 years after gestational diabetes.
Hunger-Dathe W; Mosebach N; Sämann A; Wolf G; Müller UA
Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):11-7. PubMed ID: 16450311
[TBL] [Abstract][Full Text] [Related]
34. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
Jacobson GF; Ramos GA; Ching JY; Kirby RS; Ferrara A; Field DR
Am J Obstet Gynecol; 2005 Jul; 193(1):118-24. PubMed ID: 16021069
[TBL] [Abstract][Full Text] [Related]
35. Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance.
Di Cianni G; Miccoli R; Volpe L; Lencioni C; Ghio A; Giovannitti MG; Cuccuru I; Pellegrini G; Chatzianagnostou K; Boldrini A; Del Prato S
Diabet Med; 2005 Jan; 22(1):21-5. PubMed ID: 15606686
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy.
Fallucca F; Dalfrà MG; Sciullo E; Masin M; Buongiorno AM; Napoli A; Fedele D; Lapolla A
Metabolism; 2006 Nov; 55(11):1451-6. PubMed ID: 17046546
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes.
Kinalski M; Telejko B; Kuźmicki M; Kretowski A; Kinalska I
Horm Metab Res; 2005 Jul; 37(7):450-4. PubMed ID: 16034719
[TBL] [Abstract][Full Text] [Related]
38. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
Festa A; Williams K; Tracy RP; Wagenknecht LE; Haffner SM
Circulation; 2006 Apr; 113(14):1753-9. PubMed ID: 16585388
[TBL] [Abstract][Full Text] [Related]
39. Plasminogen activator inhibitor-1 and tissue-plasminogen activator in minority adolescents with type 2 diabetes and obesity.
Umpaichitra V; Hussain MM; Castells S
Pediatr Res; 2005 Sep; 58(3):483-7. PubMed ID: 15901895
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of gestational diabetes mellitus and the effect of weight on measures of insulin secretion and insulin resistance in third-trimester pregnant rural women residing in the Central Region of Limpopo Province, South Africa.
Mamabolo RL; Alberts M; Levitt NS; Delemarre-van de Waal HA; Steyn NP
Diabet Med; 2007 Mar; 24(3):233-9. PubMed ID: 17263763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
